Journal Article Summary
The article investigates the long-term effects of captopril, a medication used to treat primary (essential) hypertension, which is a common condition characterized by high blood pressure without a known secondary cause. Understanding effective treatments for hypertension is crucial, as uncontrolled high blood pressure can lead to serious health issues, including heart disease and stroke. This study aims to evaluate how well captopril works over an extended period and its safety profile in patients with this condition.
In the study, 41 patients with primary hypertension were treated with captopril, either alone or alongside hydrochlorothiazide, for a duration of 12 to 36 months. Researchers monitored blood pressure changes during the treatment, noting significant reductions from initial high levels to much lower readings after three months. Over the long term, blood pressure remained well-controlled, with only minor variations. The study also found that while patients with low renin hypertension initially responded less favorably to treatment, their outcomes improved over time, leading to similar results as those with normal renin levels. Importantly, the treatment was generally well-tolerated, with only one case of reversible proteinuria reported.
Despite the positive findings, the study has limitations, including a relatively small sample size and the absence of a control group, which may affect the generalizability of the results. Patients should be aware of the importance of regular monitoring and communication with healthcare professionals when undergoing treatment for hypertension. Discussing any concerns or side effects experienced during treatment is essential for ensuring safety and effectiveness in managing blood pressure.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Karlberg Bengt E., Asplund Johan, Wettre Staffan, Öhman K. Peter, Nilsson Ove R.. Long-term experience of captopril in the treatment of primary (essential) hypertension. British Journal of Clinical Pharmacology 1982. DOI: 10.1111/j.1365-2125.1982.tb02070.x. PMID: 6753894. PMCID: PMC1427527.
Featured Pill Pals Product
Hydrochlorothiazide 12.5 mg Capsules --- Generic For Microzide --- ScieGen
Hydrochlorothiazide 12.5 mg Capsules — Generic For Microzide — ScieGen is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
